PUBLISHER: KBV Research | PRODUCT CODE: 1534611
PUBLISHER: KBV Research | PRODUCT CODE: 1534611
North America Human Insulin Market Size, Share & Trends Analysis Report By Indication, By Product Type (Pens, Syringes, and Others), By Type of Insulin, By Distribution Channel, By Country and Growth Forecast, 2024 - 2031
The North America Human Insulin Market would witness market growth of 2.7% CAGR during the forecast period (2024-2031).
The US market dominated the North America Human Insulin Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $5,044.3 million by 2031. The Canada market is experiencing a CAGR of 4.9% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 4% during (2024 - 2031).
Diabetes is a chronic disorder that affects millions of individuals. Since the discovery of insulin, the market for insulin has undergone substantial development, and it now plays an essential part in the management of diabetes. The need for effective diabetes treatments has increased in tandem with the increasing prevalence of diabetes, which is influenced by factors such as elderly populations, unhealthy diets, and sedentary lifestyles. Particularly for patients with type 1 diabetes and those with advanced type 2 diabetes, insulin, a hormone that is indispensable for managing blood glucose levels, continues to be a fundamental component of diabetes treatment.
The growing number of people who are diagnosed with diabetes is one of the key factors that is driving market expansion. This concerning trend emphasizes the pressing necessity for insulin-based diabetes management solutions. The prevalence of diabetes is not exclusively prevalent in high-income countries; it is also increasing at a rapid pace in low- and middle-income countries, where healthcare systems frequently encounter difficulties in managing the burden of chronic diseases.
Public health initiatives focused on diabetes prevention and management further support market growth in North America. Programs like the National Diabetes Prevention Program (NDPP) in the United States aim to reduce the incidence of type 2 diabetes through lifestyle interventions and education. In Canada, the Diabetes 360° initiative advocates for a national diabetes strategy to improve prevention, care, and outcomes for diabetic patients. These initiatives raise awareness about diabetes, promote early detection, and encourage adherence to treatment regimens, increasing the demand for insulin. Therefore, the region presents lucrative growth opportunities for the market in the coming years.
Based on Indication, the market is segmented into Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes. Based on Product Type, the market is segmented into Pens, Syringes, and Others. Based on Type of Insulin, the market is segmented into Rapid-acting insulin, Short-acting insulin, Intermediate-acting insulin, and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Providers. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- MannKind Corporation
- Lupin Limited
- Sanofi S.A.
- Novo Nordisk A/S
- Eli Lilly And Company
- Medtronic PLC
- Biocon Limited
- Tonghua Dongbao Pharmaceutical Co., Ltd.
- Pfizer, Inc.
North America Human Insulin Market Report Segmentation
By Indication
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes
By Product Type
- Pens
- Syringes
- Others
By Type of Insulin
- Rapid-acting insulin
- Short-acting insulin
- Intermediate-acting insulin
- Others
By Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- Online Providers
By Country
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Human Insulin Market, by Indication
- 1.4.2 North America Human Insulin Market, by Product Type
- 1.4.3 North America Human Insulin Market, by Type of Insulin
- 1.4.4 North America Human Insulin Market, by Distribution Channel
- 1.4.5 North America Human Insulin Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- 3.3 Porter Five Forces Analysis
Chapter 4. North America Human Insulin Market by Indication
- 4.1 North America Type 1 Diabetes Market by Country
- 4.2 North America Type 2 Diabetes Market by Country
- 4.3 North America Gestational Diabetes Market by Country
Chapter 5. North America Human Insulin Market by Product Type
- 5.1 North America Pens Market by Country
- 5.2 North America Syringes Market by Country
- 5.3 North America Others Market by Country
Chapter 6. North America Human Insulin Market by Type of Insulin
- 6.1 North America Rapid-acting insulin Market by Country
- 6.2 North America Short-acting insulin Market by Country
- 6.3 North America Intermediate-acting insulin Market by Country
- 6.4 North America Others Market by Country
Chapter 7. North America Human Insulin Market by Distribution Channel
- 7.1 North America Hospital Pharmacies Market by Country
- 7.2 North America Drug Stores & Retail Pharmacies Market by Country
- 7.3 North America Online Providers Market by Country
Chapter 8. North America Human Insulin Market by Country
- 8.1 US Human Insulin Market
- 8.1.1 US Human Insulin Market by Indication
- 8.1.2 US Human Insulin Market by Product Type
- 8.1.3 US Human Insulin Market by Type of Insulin
- 8.1.4 US Human Insulin Market by Distribution Channel
- 8.2 Canada Human Insulin Market
- 8.2.1 Canada Human Insulin Market by Indication
- 8.2.2 Canada Human Insulin Market by Product Type
- 8.2.3 Canada Human Insulin Market by Type of Insulin
- 8.2.4 Canada Human Insulin Market by Distribution Channel
- 8.3 Mexico Human Insulin Market
- 8.3.1 Mexico Human Insulin Market by Indication
- 8.3.2 Mexico Human Insulin Market by Product Type
- 8.3.3 Mexico Human Insulin Market by Type of Insulin
- 8.3.4 Mexico Human Insulin Market by Distribution Channel
- 8.4 Rest of North America Human Insulin Market
- 8.4.1 Rest of North America Human Insulin Market by Indication
- 8.4.2 Rest of North America Human Insulin Market by Product Type
- 8.4.3 Rest of North America Human Insulin Market by Type of Insulin
- 8.4.4 Rest of North America Human Insulin Market by Distribution Channel
Chapter 9. Company Profiles
- 9.1 Biocon Limited
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Research & Development Expenses
- 9.2 Tonghua Dongbao Pharmaceutical Co., Ltd.
- 9.2.1 Company Overview
- 9.3 Lupin Limited
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Regional Analysis
- 9.3.4 Research & Development Expenses
- 9.3.5 SWOT Analysis
- 9.4 MannKind Corporation
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.5 Sanofi S.A.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expense
- 9.5.5 SWOT Analysis
- 9.6 Novo Nordisk A/S
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental & Regional Analysis
- 9.6.4 Research & Development Expenses
- 9.6.5 SWOT Analysis
- 9.7 Medtronic PLC
- 9.7.1 Company overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 SWOT Analysis
- 9.8 Eli Lilly And Company
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Regional Analysis
- 9.8.4 Research & Development Expenses
- 9.8.5 SWOT Analysis
- 9.9 Pfizer, Inc.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional & Segmental Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 SWOT Analysis
LIST OF TABLES
- TABLE 1 North America Human Insulin Market, 2020 - 2023, USD Million
- TABLE 2 North America Human Insulin Market, 2024 - 2031, USD Million
- TABLE 3 North America Human Insulin Market by Indication, 2020 - 2023, USD Million
- TABLE 4 North America Human Insulin Market by Indication, 2024 - 2031, USD Million
- TABLE 5 North America Type 1 Diabetes Market by Country, 2020 - 2023, USD Million
- TABLE 6 North America Type 1 Diabetes Market by Country, 2024 - 2031, USD Million
- TABLE 7 North America Type 2 Diabetes Market by Country, 2020 - 2023, USD Million
- TABLE 8 North America Type 2 Diabetes Market by Country, 2024 - 2031, USD Million
- TABLE 9 North America Gestational Diabetes Market by Country, 2020 - 2023, USD Million
- TABLE 10 North America Gestational Diabetes Market by Country, 2024 - 2031, USD Million
- TABLE 11 North America Human Insulin Market by Product Type, 2020 - 2023, USD Million
- TABLE 12 North America Human Insulin Market by Product Type, 2024 - 2031, USD Million
- TABLE 13 North America Pens Market by Country, 2020 - 2023, USD Million
- TABLE 14 North America Pens Market by Country, 2024 - 2031, USD Million
- TABLE 15 North America Syringes Market by Country, 2020 - 2023, USD Million
- TABLE 16 North America Syringes Market by Country, 2024 - 2031, USD Million
- TABLE 17 North America Others Market by Country, 2020 - 2023, USD Million
- TABLE 18 North America Others Market by Country, 2024 - 2031, USD Million
- TABLE 19 North America Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
- TABLE 20 North America Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
- TABLE 21 North America Rapid-acting insulin Market by Country, 2020 - 2023, USD Million
- TABLE 22 North America Rapid-acting insulin Market by Country, 2024 - 2031, USD Million
- TABLE 23 North America Short-acting insulin Market by Country, 2020 - 2023, USD Million
- TABLE 24 North America Short-acting insulin Market by Country, 2024 - 2031, USD Million
- TABLE 25 North America Intermediate-acting insulin Market by Country, 2020 - 2023, USD Million
- TABLE 26 North America Intermediate-acting insulin Market by Country, 2024 - 2031, USD Million
- TABLE 27 North America Others Market by Country, 2020 - 2023, USD Million
- TABLE 28 North America Others Market by Country, 2024 - 2031, USD Million
- TABLE 29 North America Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 30 North America Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 31 North America Hospital Pharmacies Market by Country, 2020 - 2023, USD Million
- TABLE 32 North America Hospital Pharmacies Market by Country, 2024 - 2031, USD Million
- TABLE 33 North America Drug Stores & Retail Pharmacies Market by Country, 2020 - 2023, USD Million
- TABLE 34 North America Drug Stores & Retail Pharmacies Market by Country, 2024 - 2031, USD Million
- TABLE 35 North America Online Providers Market by Country, 2020 - 2023, USD Million
- TABLE 36 North America Online Providers Market by Country, 2024 - 2031, USD Million
- TABLE 37 North America Human Insulin Market by Country, 2020 - 2023, USD Million
- TABLE 38 North America Human Insulin Market by Country, 2024 - 2031, USD Million
- TABLE 39 US Human Insulin Market, 2020 - 2023, USD Million
- TABLE 40 US Human Insulin Market, 2024 - 2031, USD Million
- TABLE 41 US Human Insulin Market by Indication, 2020 - 2023, USD Million
- TABLE 42 US Human Insulin Market by Indication, 2024 - 2031, USD Million
- TABLE 43 US Human Insulin Market by Product Type, 2020 - 2023, USD Million
- TABLE 44 US Human Insulin Market by Product Type, 2024 - 2031, USD Million
- TABLE 45 US Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
- TABLE 46 US Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
- TABLE 47 US Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 48 US Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 49 Canada Human Insulin Market, 2020 - 2023, USD Million
- TABLE 50 Canada Human Insulin Market, 2024 - 2031, USD Million
- TABLE 51 Canada Human Insulin Market by Indication, 2020 - 2023, USD Million
- TABLE 52 Canada Human Insulin Market by Indication, 2024 - 2031, USD Million
- TABLE 53 Canada Human Insulin Market by Product Type, 2020 - 2023, USD Million
- TABLE 54 Canada Human Insulin Market by Product Type, 2024 - 2031, USD Million
- TABLE 55 Canada Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
- TABLE 56 Canada Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
- TABLE 57 Canada Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 58 Canada Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 59 Mexico Human Insulin Market, 2020 - 2023, USD Million
- TABLE 60 Mexico Human Insulin Market, 2024 - 2031, USD Million
- TABLE 61 Mexico Human Insulin Market by Indication, 2020 - 2023, USD Million
- TABLE 62 Mexico Human Insulin Market by Indication, 2024 - 2031, USD Million
- TABLE 63 Mexico Human Insulin Market by Product Type, 2020 - 2023, USD Million
- TABLE 64 Mexico Human Insulin Market by Product Type, 2024 - 2031, USD Million
- TABLE 65 Mexico Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
- TABLE 66 Mexico Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
- TABLE 67 Mexico Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 68 Mexico Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 69 Rest of North America Human Insulin Market, 2020 - 2023, USD Million
- TABLE 70 Rest of North America Human Insulin Market, 2024 - 2031, USD Million
- TABLE 71 Rest of North America Human Insulin Market by Indication, 2020 - 2023, USD Million
- TABLE 72 Rest of North America Human Insulin Market by Indication, 2024 - 2031, USD Million
- TABLE 73 Rest of North America Human Insulin Market by Product Type, 2020 - 2023, USD Million
- TABLE 74 Rest of North America Human Insulin Market by Product Type, 2024 - 2031, USD Million
- TABLE 75 Rest of North America Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
- TABLE 76 Rest of North America Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
- TABLE 77 Rest of North America Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 78 Rest of North America Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 79 Key Information - Biocon Limited
- TABLE 80 Key Information - Tonghua Dongbao Pharmaceutical Co., Ltd.
- TABLE 81 Key Information - Lupin Limited
- TABLE 82 Key Information - MannKind Corporation
- TABLE 83 Key Information - Sanofi S.A.
- TABLE 84 Key Information - Novo Nordisk A/S
- TABLE 85 Key Information - Medtronic PLC
- TABLE 86 Key Information - Eli Lilly And Company
- TABLE 87 Key Information - Pfizer, Inc.
